Benchmark has decided to maintain its Buy rating of Transphorm (NASDAQ:TGAN) and raise its price target from $8.00 to $8.00.
Shares of Transphorm are trading up 0.0% over the last 24 hours, at $2.17 per share.
Support authors and subscribe to content
This is premium stuff. Subscribe to read the entire article.
Login if you have purchased